Clinical trial
OSI-774 (Erlotinib, Tarceva) in Elderly Patients
NCT00200395 · Montefiore Medical Center, Other · Completed
Key facts
| NCT number | NCT00200395 |
|---|---|
| Title | OSI-774 (Erlotinib, Tarceva) in Elderly Patients |
| Official title | Phase II Study of OSI-774 (Erlotinib, Tarceva) in Elderly Patients With Advanced Stage or Inoperable Non Small Cell Lung Cancer (NSCLC) |
| Lead sponsor | Montefiore Medical Center, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Tarceva |
| Enrollment | 30 |
| Start date | Jul 2, 2003 |
| Primary completion | Jan 12, 2007 |
| Completion | Jan 12, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Dec 30, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: